The exchange of WuXi shares for cash and Charles River shares is normally expected to end up being taxable to WuXi’s shareholders under U.S. Tax law. Charles River stock will continue to be listed on the NYSE under the symbol CRL. Funding Charles River intends to financing the cash portion of the purchase through balance sheet cash on hand and a number of sources of new debts funding. Charles River offers received a financing dedication for a $1.25 billion credit facility from J.P. Morgan Lender and Chase of America Merrill Lynch.. Charles River Laboratories International, WuXi PharmaTech sign definitive agreement to combine Charles River Laboratories International, Inc. , a leading global provider of analysis models and associated providers and of preclinical medication development providers, and WuXi PharmaTech Inc.Epitopes are bits of a virus that your body’s immune system targets when it starts an immune response. By understanding which epitopes will bind to the MHC molecule and trigger an immune attack, researchers may use those epitopes to build up a vaccine to defend against illness – in this instance to smallpox. Related StoriesKey component of MRSA vaccine puzzle unearthedNew vaccine applicant shows great guarantee at fighting respiratory syncytial virusGHIT Fund invests $10.7 million to battle malaria, TB, leishmaniasis and dengueThe researchers could actually find 95 % of the MHC binding epitopes through the computer modeling.